Answers are grounded in this paper and cite their sources.
H uman leishmaniasis is a vectorborne disease oc- curring mostly in Central and South America, the Europe/Africa Mediterranean area, the Middle East, and the Indian subcontinent.This disease is caused by parasites in the Leishmania subgenera Viannia and Leishmania, affects ≈2.5 million persons, and causes 60,000 deaths yearly worldwide (1).The disease has 3 main clinical forms: cutaneous leishmaniasis (CL), the most prevalent form and caused by species in both Viannia and Leishmania subgenera; mucocutaneous leishmaniasis, caused by species in the subgenus Viannia; and visceral leishmaniasis, caused by L. (L.) donovani and L. (L.) infantum.These syndromes might lead to social stigma because of permanent scars, skin disfi gurement, and partial/total destruction of oral/ nasopharyngeal mucosa and can result in systemic symptoms including splenomegaly, wasting, and even death (2).Species-specifi c Leishmania identifi cation is critical in clinical management and epidemiologic investigations (2).Detection and identification of Leishmania parasites were traditionally done through microscopic and multilocus enzyme electrophoresis analysis.Currently, PCR-based methods and multilocus DNA sequence analyses (MLSA) combined with next-generation sequencing, have improved phylogenetic resolution and provided insights into parasite identifi cation, classifi cation, genetic polymorphism, virulence, and drug resistance (3,4).Leishmania parasites are emerging in previously nonendemic areas (5); traditional and exotic Leishmania species/strains have been reported in focal areas of the Americas, Europe, Africa, Asia, and the Western Pacifi c (6).In the United States, leishmaniasis is mostly nonreportable and historically considered a travel-associated disease.However, the activity of natural vectors of Leishmania and occurrence of autochthonous zoonotic cases of CL and visceral leishmaniasis caused by L. (L.) mexicana or L. (L.) infantum have been reported in several states, including Alabama, Arizona, Arkansas, Delaware, Georgia, Kentucky, Louisiana, Maryland, Mississippi, Ohio, Oklahoma, South Carolina,.Those reports suggest the possibility of local transmission of leishmaniasis, especially in the southwestern US region.We report an autochthonous case of CL from Arizona, USA, caused by an unknown parasite in the subgenus Leishmania. The StudyIn December 2017, a 72-year-old woman from Pima County, Arizona, sought medical care for 2 discrete, progressive, edematous, violaceous papular lesions on the low back.The patient had a history of granulomatosis with polyangiitis, chronic sinusitis, chronic kidney disease, and pulmonary coccidioidomycosis.The patient had never traveled internationally and did not have an underlying health condition predisposing her to leishmaniasis.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: